Reata Pharmaceuticals (RETA) Reports Q2 Loss of $0.05/Share

August 11, 2016 5:04 PM EDT
Get Alerts RETA Hot Sheet
Price: $23.16 +0.52%

Today's EPS Names:
BRO, FCFP, PRK, More
Trade RETA Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Reata Pharmaceuticals (NASDAQ: RETA) reported Q2 EPS of ($0.05), versus ($0.11) reported last year. Revenue for the quarter came in at $12.4 million, versus $12.4 million reported last year.

For earnings history and earnings-related data on Reata Pharmaceuticals (RETA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment